研究業績

1999年

原著論文

  1. Ashihara E, Shimazaki C, Okamoto A, Shimura K, Takahashi R, Sumikuma T, Hirai H, Inaba T, Fujita N, Nakagawa M: Successful peripheral blood stem cell transplantation for myelodysplastic syndrome. Bone Marrow Transplant. 24(12): 1343-5, 1999.
  2. Shimazaki C, Inaba T, Shimura K, Okamoto A, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K, Fujita N, Nakagawa M: B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study. Br J Haematol. 104(4): 672-9, 1999.
  3. Hirai H, Shimura K, Takahashi R, Kikuta T, Ashihara E, Inada T, Fujita N, Shimazaki C, Akasaka T, Ohno H, Nakagawa M: CD5 positive B cell leukemic lymphoma associated with BCL6 rearrangement. Japanese Journal of Clinical Hematology. 40(11):1198-200, 1999.
  4. Sumikuma T, Kikuta T, Hirai H, Sudo Y, Yamagata N, Ashihara E, Goto H, Inaba T, Fujita N, Murakami S, Haruyama H, Shimazaki C, Nakagawa M: Discrimination of leukoencephalopathy from leukemic cell invasion by MR spectroscopy in a patient with acute lymphoblastic leukemia. Japanese Journal of Clinical Hematology. 40(4):305-10, 1999.

学会発表

  1. Mazda O, Maruyama-Tabata H, Harada Y, Satoh E, Nomura M, Tanaka S, Hirai H, Iwai M, Okanoue T, Kashima K, Matsumura T, Sawada T, Imanishi J: The EBV/polyplex: an efficient non-viral system for in vitro and in vivo gene delivery. The American Society of Gene Therapy, 2nd Annual Meeting, Washington DC, 1999.
  2. Tomiyasu K, Oda Y, Iida Y, Kondo M, Nomura M, Hirai H, Satoh E, Imanishi J and Mazda O. Direct intracardiomuscular gene transfer of naked DNA encoding β2 adrenergic receptor (AR) augments cardiac output (CO) in cardiomyopathic hamster. American Heart Association, Atlanta, 1999.
  3. Iwai M, Tanaka S, Harada Y, Muramatsu A, Mori T, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J and Mazda O: Gene therapy for chollangiocellular carcinoma (CCC) using Epstein Barr virus (EBV)-based plasmid vector/polyamidoamine dendrimer (EBV/polyplex). 17th ISOBM, Kyoto, 1999.
  4. Tanaka S, Iwai M, Harada Y, Morikawa T, Muranatsu A, Mori T, Okanoue T, Kashima K, Maruyama-Tabata H, Hirai H, Satoh E, Imanishi J, Mazda O: Gene therapy for chollangiocellular carcinoma (CCC) using Epstein-Barr virus (EBV)-based plasmid vector/polyamidoamine dendrimer. 50th Annual Meeting of the American Association for the Study of Liver Diseases, Dallas, 1999.

その他

  1. 島崎千尋, 平位秀世: 3)その他の固形腫瘍. 症例に学ぶG-CSFの臨床. 医薬ジャーナル社. 大阪: pp127-136, 1999.

 

1998年

原著論文

  1. Feng R, Shimazaki C, Inaba T, Takahashi R, Hirai H, Kikuta T, Sumikuma T, Yamagata N, Ashihara E, Fujita N, Nakagawa M: CD34+/CD41a+ cells best predict platelet recovery after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 21(12): 1217-22, 1998.
  2. Ashihara E, Shimazaki C, Sudo Y, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M: FLT-3 ligand mobilizes hematopoietic primitive and committed progenitor cells into blood in mice. Eur J Haematol. 60(2): 86-92, 1998.
  3. Suehiro M, Kishimoto S, Wakabayashi T, Ikeuchi A, Miyake H, Takenaka H, Okano A, Hirai H, Shimazaki C, Yasuno H: Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer. Br J Dermatol. 139(4): 748-9, 1998.
  4. Inaba T, Shimazaki C, Sumikuma T, Shimura K, Takahashi R, Hirai H, Ashihara E, Sudo Y, Murakami S, Haruyama H, Fujita N, Yoshimura M, Nakagawa M: Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome. Int J Hematol. 68(4): 403-10, 1998.
  5. Satoh E, Hirai H, Inaba T, Shimazaki C, Nakagawa M, Imanishi J, Mazda O: Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors. FEBS Lett. 441(1): 39-42, 1998.

学会発表

  1. Hirai H, Satoh E, Inaba T, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: Targeted gene therapy of EBV-associated neoplasms by using EBV-based vector/HVJ-liposome complex vector. Keystone symposia on molecular and cellular biology of gene therapy, Keystone, 1998.
  2. Hirai H, Satoh E, Inaba T, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: Successful transduction of adenosine deaminase (ADA) gene in vitro into human peripheral blood stem cells (PBSC) by transfecting Epstein-Barr virus (EBV)-based episomal vectors. Keystone symposia on molecular and cellular biology of gene therapy. Keystone, 1998.
  3. Hirai H, Satoh E, Inaba T, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: Targeted killing in vitro and in vivo of EBV-associated neoplasms by EBV-based episomal vectors/ HVJ-liposome complex vector system. Second scientific sessions of American society for gene therapy, Seattle, 1998.
  4. Satoh E, Hirai H, Inaba T, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: Transduction of ADA gene into human CD34+ hematopoietic progenitor cells by means of the Epstein-Barr virus (EBV)-based episomal vectors. Second scientific sessions of American society for gene therapy, Seattle, 1998.
  5. Satoh E, Hirai H, Inaba T, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: Gene transduction into human hematopoietic progenitor cells by using Epstein-Barr virus (EBV) –based episomal vectors. Second conference on stem cell gene therapy: biology and technology, Orcas, 1998.
  6. Mazda O, Harada Y, Tabata H, Hirai H, Satoh E, Nomura M, Iwai M, Shimazaki C, Matsumura T, Okanoue T, Nakagawa M, Sawada T, Kashima K, Imanishi J: Epstein-Barr virus (EBV)-based episomal vector as a tool for cancer gene therapy．The 7th International Conference on Gene Therapy of Cancer, San Diego, 1998.
  7. Shimazaki C, Inaba T, Shimura K, Okamoto A, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K, Fujita N and Nakagawa M: B-cell lymphoma associated with hemophagocytic syndrome: a clinical, immunological and cytogenetic study. 40th annual meeting of the America Society of Hematology, Miami, 1998.
  8. 松田修, 平位秀世, 佐藤悦子, 稲葉亨, 島崎千尋, 中川雅夫, 今西二郎: EBV関連腫瘍の特異的自殺遺伝子治療. 第46回日本ウイルス学会学術集会, 東京, 1998.
  9. 平位秀世, 松田修, 佐藤悦子, 稲葉亨, 島崎千尋, 中川雅夫, 今西二郎: EBNA/OriP系のプラスミドDNAの複製・維持における機能解析. 第46回日本ウイルス学会学術集会, 東京, 1998.
  10. 松田修, 佐藤悦子, 平位秀世, 原田義規, 岩井眞樹, 稲葉亨, 岡上武, 島崎千尋, 加嶋敬, 中川雅夫, 今西二郎: EBV (Epstein-Barr virus) エピゾーマル・ベクターの遺伝子治療. 第5回日本遺伝子診療学会, 東京, 1998.
  11. Hirai H, Satoh E, Inaba T, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: Targeted gene therapy in vitro and in vivo for EBV-associated neoplasms using EBV-based episomal vectors. 第4回日本遺伝子治療学会総会, 東京, 1998.
  12. 平位秀世, 佐藤悦子, 岡本昭夫, 志村和穂, 高橋良一, 芦原英司, 稲葉亨, 藤田直久, 島崎千尋, 中川雅夫, 松田修, 今西二郎: EBウイルス関連腫瘍細胞での特異的遺伝子発現と標的自殺遺伝子療法への応用. 第57回日本癌学会総会, 横浜, 1998.

 

1997年

原著論文

  1. Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M: Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood. 89(9): 3186-91, 1997.
  2. Hirai H, Satoh E, Osawa M, Inaba T, Shimazaki C, Kinoshita S, Nakagawa M, Mazda O, Imanishi J: Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms. Biochem Biophys Res Commun. 241(1): 112-8, 1997.
  3. Yamagata N, Shimazaki C, Kikuta T, Hirai H, Sumikuma T, Sudo Y, Ashihara E, Goto H, Inaba T, Fujita N, Nakagawa M: A translocation between 3q21 and 12q24 in a patient with minimally differentiated acute myeloid leukemia (AML-M0). Cancer Genet Cytogenet. 97(2): 90-3, 1997.
  4. Hirai H, Shimazaki C, Yamagata N, Goto H, Inaba T, Kikuta T, Sumikuma T, Sudo Y, Ashihara E, Fujita N, Hibi S, Imashuku S, Ito E, Nakagawa M: Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia. Eur J Haematol. 59(1): 38-46, 1997.
  5. Shimazaki C, Goto H, Araki S, Tatsumi T, Takahashi R, Hirai H, Kikuta T, Yamagata N, Ashihara E, Inaba T, Fujita N, Suzuki R, Nakagawa M: Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32). Int J Hematol. 66(1): 111-5, 1997.
  6. Shimazaki C, Inaba T, Uchiyama H, Sumikuma T, Kikuta T, Hirai H, Sudo Y, Yamagata N, Ashihara E, Goto H, Murakami S, Haruyama H, Fujita N, Nakagawa M: Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant.19(8): 771-5, 1997.
  7. Inaba T, Shimazaki C, Sumikuma T, Takahashi R, Hirai H, Kikuta T, Sudo Y, Yamagata N, Ashihara E, Goto H, Fujita N, Yoshimura M, Nakagawa M: Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia. Int J Hematol. 66(3): 315-23, 1997.
  8. Satoh E, Osawa M, Tomiyasu K, Hirai H, Shimazaki C, Oda Y, Nakagawa M, Kondo M, Kinoshita S, Mazda O, Imanishi J: Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome. Biochem Biophys Res Commun. 238(3): 795-9, 1997.

学会発表

  1. Satoh E, Hirai H, Inaba T, Shimazaki C, Nakagawa M, Mazda O, Imanishi J: Elevated Adenosine Deaminase (ADA) Activity in Peripheral Blood Stem Cells (PBSC) Transduced In Vitro with ADA Gene by Epstein-Barr Virus (EBV)-Based Vectors. The 3rd Annual Meeting. The Japan Society of Gene Therapy, Tokyo, 1997.
  2. Satoh E, Hirai H, Inaba T, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: The Epstein-Barr virus-based episomal vector as a novel tool to transfect genes into human hematopoietic stem cells. The 39th annual meeting of America society of hematology, San Diego, 1997.
  3. Shimazaki C, Kikuta T, Ashihara E, Sudo Y, Takahashi R, Hirai H, Sumikuma T, Yamagata N, Inaba T, Fujita N and Nakagawa M: Anti VCAM-1 antibody effectively mobilizes stem and progenitor cells into blood in mice. The 39th annual meeting of America society of hematology, San Diego, 1997.
  4. Hirai H, Satoh E, Takahashi R, Kikuta T, Sumikuma T, Yamagata N, Ashihara E, Inaba T, Fujita N, Shimazaki C, Nakagawa M, Mazda O, Imanishi J: Successful Gene Transduction into Human CFCs Using Epstein-Barr Virus-Based Vectors. The 3rd Annual Meeting. The Japan Society of Gene Therapy, Tokyo, 1997.
  5. Hirai H, Satoh E, Takahashi R, Kikuta T, Sumikuma T, Yamagata N, Ashihara E, Inaba T, Fujita N, Shimazaki C, Nakagawa M, Mazda O and Imanishi J: Successful gene transduction into human peripheral bood stem cell using Epstein-Barr virus-based vectors. 26th annual meeting of the international society for Experimental Hematology, Cannes, 1997.
  6. 平位秀世, 佐藤悦子, 志村和穂, 高橋良一, 芦原英司, 稲葉亨, 藤田直久, 島崎千尋, 中川雅夫, 松田修, 今西二郎: EBVベクターによるHSV-1 Tk遺伝子のEBウイルス関連腫瘍における特異的発現. 第56回日本癌学会総会, 京都, 1997.

 

1996年

原著論文

  1. Inaba T, Shimazaki C, Hirai H, Kikuta T, Sumikuma T, Sudo Y, Yamagata N, Ashihara E, Goto H, Fujita N, Nakagawa M： Familial polycythemia vera in father and daughter. Am J Hematol. 51(2): 172, 1996.
  2. Inaba T, Shimazaki C, Yoneyama S, Hirai H, Kikuta T, Sumikuma T, Sudo Y, Yamagata N, Ashihara E, Goto H, Fujita N, Nakagawa M: t(7;11) and trilineage myelodysplasia in acute myelomonocytic leukemia. Cancer Genet Cytogenet. 86(1): 72-5, 1996.
  3. Kikuta T, Shimazaki C, Hirai H, Sumikuma T, Sudo Y, Yamagata N, Ashihara E, Goto H, Inaba T, Fujita N, Hatta T, Nakagawa M: Three cases of secondary acute myeloid leukemia after long-term treatment with oral etoposide. Japanese Journal of Clinical Hematology. 37(11):1276-82, 1996.

学会発表

  1. Hirai H, Shimazaki C, Goto H, Inaba T, Kikuta T, Sumikuma T, Sudo Y, Yamagata N, Ashihara E, Fujita N, Hibi S, Ito E and Nakagawa M: Thrombopoietin induces growth response of acute megakaryocytic leukemia and transient abnormal myelopoiesis. The 24th congress of the international society of blood transfusion, Makuhari, 1996.
  2. Shimazaki C, Inaba T, Uchiyama T, Sumikuma T, Hirai H, Sudo Y, Yamagata N, Ashihara E, Goto H, Fujita N and Nakagawa M: Serum thrombopoietin level of thrombopoietin in patients undergoing peripheral blood stem cell transplantation. Blood cell transplantation. Fourth international symposium, Adelaide, 1996.
  3. Shimazaki C, Inaba T, Uchiyama T, Sumikuma T, Hirai H, Sudo Y, Yamagata N, Ashihara E, Goto H, Fujita N and Nakagawa M: Serum thrombopoietin levels in patients undergoing stem cell transplantation. 4th Japan-China symposium on hematology under the cooperation of two societies, Kyoto, 1996.
  4. Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N and Nakagawa M: Flt-3 ligand mobilizes hematopoietic stem/ progenitor cells into blood in combination with G-CSF. The 24th congress of the international society of blood transfusion, Makuhari, 1996.
  5. 芦原英司, 島崎千尋, 須藤良和, 菊田武久, 平位秀世, 角熊俊也, 山形昇, 後藤秀夫, 稲葉亨, 藤田直久, 中川雅夫: FlT-3 ligandによる末梢血幹細胞の動員効果. 第58回日本血液学会総会, 宇都宮, 1996.
  6. 稲葉亨, Ru Feng, 角熊俊也, 菊田武久, 平位秀世, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 藤田直久, 島崎千尋, 中川雅夫: 自己PBSCTでの輸注幹細胞における血小板関連抗原の発現と移植後血小板回復との相関. 第19回日本造血細胞移植学会, 岡山, 1996.
  7. 稲葉亨, 島崎千尋, 角熊俊也, 内山人二, 菊田武久, 平位秀世, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 藤田直久, 中川雅夫: 造血幹細胞移植における血清thrombopoietin濃度の推移. 第58回日本血液学会総会, 宇都宮, 1996
  8. 稲葉亨, 藤田直久, 高橋良一, 菊田武久, 角熊俊也, 平位秀世, 山形昇, 芦原英司, 後藤秀夫, 島崎千尋, 中川雅夫: 各種造血器腫瘍細胞におけるThy-1発現について. 第38回日本臨床血液学会総会, 大宮, 1996.
  9. 角熊俊也, 稲葉亨, 島崎千尋, 平位秀世, 菊田武久, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 藤田直久, 中川雅夫: 末梢血CD34陽性細胞におけるThy-1発現について. 第58回日本血液学会総会, 宇都宮, 1996.
  10. 角熊俊也, 高橋良一, 菊田武久, 平位秀世, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 島崎千尋, 中川雅夫: 末梢血幹細胞採取時におけるCD34陽性/Thy-1陽性細胞の 亜分画について. 第58回日本血液学会総会, 宇都宮, 1996.
  11. 角熊俊也, 稲葉亨, 平位秀世, 菊田武久, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 藤田直久, 島崎千尋, 中川雅夫: フローサイトメトリーを用いたCD34陽性急性白血病におけるThy-1発現の検討. 第55回日本癌学会総会, 横浜, 1996.
  12. 菊田武久, 島崎千尋, 高橋良一, 平位秀世, 角熊俊也, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 中川雅夫: 末梢血幹細胞移植を行った固形腫瘍15例の検討, 第19回日本造血細胞移植学会, 岡山, 1996.
  13. 菊田武久, 島崎千尋, 須藤良和, 芦原英司, 高橋良一, 平位秀世, 角熊俊也, 山形昇, 後藤秀夫, 稲葉亨, 藤田直久, 中川雅夫. 抗VCAM-1抗体によるマウス造血幹細胞への末梢血への動員効果. 第38回日本臨床血液学会総会, 大宮, 1996.
  14. 高橋良一, 平位秀世, 菊田武久, 角熊俊也, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 島崎千尋, 中川雅夫, 有馬靖佳: Lymphoblastic lymphomaに対する末梢血幹細胞移植. 第38回日本臨床血液学会総会, 大宮, 1996.
  15. 阪本健三, 島崎千尋, 高橋良一, 菊田武久, 角熊俊也, 平位秀世, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 中川雅夫, 村頭智, 春山春江: IdarubicineとAra-Cの併用が著効を示したRAEB in Tの2例. 第65回近畿血液学地方会, 神戸, 1996.
  16. 阪本健三, 島崎千尋, 山形昇, 高橋良一, 菊田武久, 角熊俊也, 平位秀世, 須藤良和, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 中川雅夫: t(3;12)(q21;q24)を呈したMinimally differentiated acute myeloid leukemia (M0)の一例. 第38回日本臨床血液学会総会, 大宮, 1996.
  17. 山形昇, 島崎千尋, 高橋良一, 平位秀世, 菊田武久, 角熊俊也, 須藤良和, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 中川雅夫: 化学療法とG-CSFを用いた末梢血幹細胞動員両方の検討. 第38回日本臨床血液学会総会, 大宮, 1996.
  18. 平位秀世, 佐藤悦子, 稲葉亨, 島崎千尋, 中川雅夫, 松田修, 今西二郎: EBVベクターを用いたヒト造血幹細胞への遺伝子導入療法の開発I。マーカー遺伝子の導入. 第26回日本免疫学会, 横浜, 1996.
  19. 佐藤悦子, 平位秀世, 稲葉亨, 島崎千尋, 中川雅夫, 松田修, 今西二郎: EBVベクターを用いたヒト造血幹細胞への遺伝子導入療法の開発II。ADA遺伝子の導入. 第26回日本免疫学会, 横浜, 1996.

 

1995年

学会発表

  1. Ashihara E, Shimazaki C, Sudo Y, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M: In vivo effect of FLT-3 ligand in mice. Bone Marrow Transplantation – Basic and Clinical Studies. Springer-Verlag Tokyo: 146-149, 1996.
  2. Shimazaki C, Goto H, Ashihara E, Yamagata N, Hirai H, Kikuta T, Sumikuma T, Sudo Y, Inaba T, Fujita N, Nakagawa M: Hematopoietic reconstitution after peripheral blood stem cell transplantation: effects of granulocyte colony-stimulating factor and progenitor cell dose. Bone Marrow Transplantation – Basic and Clinical Studies. Springer-Verlag Tokyo: pp68-72, 1996.
  3. Ashihara E, Shimazaki C, Sudo Y, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N and Nakagawa M: FLT-3 ligand mobilizes hematopoietic stem/progenitor cells into blood in mice. 24th annual meeting of the International Society for Experimental Hematology, Dusseldorf, 1995.
  4. Ashihara E, Shimazaki C, Sudo Y, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N and Nakagawa M: In vitro effects of FLT-3 ligand in mice. International symposium on bone marrow transplantation, Tokyo, 1995.
  5. Ashihara E, Shimazaki C, Sudo Y, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N and Nakagawa M: FLT-3 ligand synergistically enhances the in vivo response to G-CSF for mobilizing hematopoietic stem/progenitor cells into blood in mice. The 37th annual meeting of the American Society of Hematology, Seattle,1995.
  6. Shimazaki C, Sudo Y, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Ashihara E, Goto H, Inaba T, Fujita N and Nakagawa M: Effects of Filgrastim (G-CSF) and progenitor cell dose on the hematopoietic recovery after peripheral blood stem cell transplantation. International symposium on bone marrow transplantation, Tokyo,1995.
  7. Hirai H, Shimazaki C, Goto H, Inaba T, Kikuta T, Sumikuma T, Sudo Y, Yamagata N, Ashihara E, Fujita N, Hibi S, Ito E and Nakagawa M: Effects of recombinant human thrombopoietin on the proliferation of acute myeloblastic leukemia and transient abnormal myelopoiesis. The 37th annual meeting of the American Society of Hematology, Seattle, 1995.
  8. 稲葉亨, 島崎千尋, 菊田武久, 角熊俊也, 平位秀世, 須藤良和, 山形昇, 芦原英司, 後藤秀夫, 藤田直久, 林, 謙宏, 中田哲雄, 西尾晃, 春山春江, 中川雅夫: 遺伝子組み替え型interferon-α-2b (IFN-α-2b)の慢性骨髄性白血病(CML)に対する治療効果. 第37回日本臨床血液学会総会, 京都, 1995.
  9. 島崎千尋, 平位秀世, 山形昇, 中川雅夫:白血病細胞に対するthrombopoietinの作用. 平成七年度厚生省班会議「成人難治性白血病班」, 名古屋, 1995.
  10. 原田英彦, 兵庫匡幸, 菊田武久, 平位秀世, 角熊俊也, 新木真一, 須藤良和, 辰巳哲也, 平田俊幸, 山形昇, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 島崎千尋, 中川雅夫: Retinoic acid (RA)症候群を発症したAPLの一例:白血球表面抗原と血清サイトカイン濃度の変動. 第37回日本臨床血液学会総会, 京都, 1995.
  11. 平位秀世, 菊田武久, 角熊俊也, 新木真一, 須藤良和, 辰巳哲也, 平田俊幸, 山形昇, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 島崎千尋, 中川雅夫: 巨核芽球性白血病の増殖・分化に及ぼすrhTPO(c-mpl ligand)の効果について, 第37回日本臨床血液学会総会, 京都, 1995.
  12. 藤田直久, 稲葉亨, 角熊俊也, 菊田武久, 平位秀世, 須藤良和, 辰巳哲也, 山形昇, 芦原英司, 後藤秀夫, 島崎千尋, 中川雅夫: インターフェロン投与中止後もフィラデルフィア染色体の減少を認めた慢性骨髄性白血病の一例. 第64回近畿血液学地方会, 大津, 1995.

 

1994年

学会発表

  1. 平位秀世, 新木真一, 須藤良和, 辰巳哲也, 山形昇, 芦原英司, 後藤秀夫, 稲葉亨, 藤田直久, 島崎千尋, 中川雅夫: 20年間生存中の慢性骨髄性白血病(CML)の一例. 第36回日本臨床血液学会総会, 東京, 1994.